Filing Details

Home > Insider Trading > Latest 13D and 13G Filings > 13G Filing (0001193125-21-043299)

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Delaware Street Capital Master Fund, L.P.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) ☐ (b) ☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

Cayman Islands

Accession Number:: 0001193125-21-043299
Form Type:: 13G Filing
Publication Date:: 2021-02-16 07:01:52

Filed By:: Delaware Street Capital Master Fund, L.p.
Company:: Zevra Therapeutics Inc. (NASDAQ:ZVRA)
Filing Date:: 2021-02-16
SEC Url:: 13G Filing

Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name	Sole Voting Power	Shared Voting Power	Sole Dispositive Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Delaware Street Capital Master Fund	159,364	0	159,364	0	159,364	3.4%
DSC Advisors	0	159,364	0	159,364	159,364	3.4%
DSC Managers	0	159,364	0	159,364	159,364	3.4%
DSC Advisors	0	159,364	0	159,364	159,364	3.4%
Andrew G. Bluhm	0	159,364	0	159,364	159,364	3.4%

Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 13G/A

(Rule 13d-102)

Amendment No. 6

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

KemPharm, Inc.

(Name of Issuer)

Common Stock, par value $0.0001

(Title of Class of Securities)

488445206

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐

Rule 13d-1(b)

☒

Rule 13d-1(c)

☐

Rule 13d-1(d)


CUSIP No. 488445206

*	SEE INSTRUCTIONS BEFORE FILLING OUT

**	SEE ITEM 4(b).


CUSIP No. 488445206

*	SEE INSTRUCTIONS BEFORE FILLING OUT

**	SEE ITEM 4(b).


CUSIP No. 488445206

*	SEE INSTRUCTIONS BEFORE FILLING OUT

**	SEE ITEM 4(b).


CUSIP No. 488445206

*	SEE INSTRUCTIONS BEFORE FILLING OUT

**	SEE ITEM 4(b).


CUSIP No. 488445206

*	SEE INSTRUCTIONS BEFORE FILLING OUT

**	SEE ITEM 4(b).

SCHEDULE 13G/A

This Amendment No. 6 (this Amendment) to the Schedule 13G (the Schedule 13G) relates to shares of Common Stock, par value $0.0001 (Common Stock), of KemPharm, Inc., a Delaware corporation (the Issuer), and is being filed on behalf of (i) Delaware Street Capital Master Fund, L.P. (the Fund), a Cayman Islands exempted limited partnership, (ii) DSC Advisors, L.P. (DSCA), a Delaware limited partnership, as investment manager to the Fund, (iii) DSC Managers, L.L.C (DSCM), a Delaware limited liability company, as the general partner of the Fund, (iv) DSC Advisors, L.L.C. (DSCA LLC), a Delaware limited liability company, as the general partner of DSCA, and (v) Andrew G. Bluhm, the principal of DSCA LLC (the persons mentioned in (ii), (iii), (iv) and (v) above are referred to herein as the Delaware Street Capital Group, and, together with the Fund, the Reporting Persons). All shares of Common Stock are held by the Fund.

This Amendment amends and restates the Schedule 13G as set forth below.

Item 1(a)

Name of Issuer.

KemPharm, Inc.

Item 1(b)

Address of Issuers Principal Executive Offices.

1180 Celebration Boulevard

Suite 103

Celebration, FL, 34747

Item 2(a)

Name of Person Filing.

(i) Delaware Street Capital Master Fund, L.P., (ii) DSC Advisors, L.P. (iii) DSC Managers, L.L.C, (iv) DSC Advisors, L.L.C. and (v) Andrew G. Bluhm.

Item 2(b)

Address of Principal Business Office, or, if none, Residence.

900 North Michigan, Suite 1600

Chicago, IL 60611

Item 2(c)

Citizenship or Place of Organization.

The Fund is a Cayman Islands exempted limited partnership. DSCA is a Delaware limited partnership. DSCM is a Delaware limited liability company. DSCA LLC is a Delaware limited liability company. Mr. Bluhm is a United States citizen.

Item 2(d)

Title of Class of Securities.

Common Stock, par value $0.0001 (the Common Stock).

Item 2(e)

CUSIP Number.

488445206

Item 3

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Inapplicable.

Item 4

Ownership.

(a)

The Fund may be deemed the beneficial owner of 159,364 shares of Common Stock. The Delaware Street Capital Group may be deemed the beneficial owner of 159,364 shares of Common Stock.

(b)

The Reporting Persons may be deemed the beneficial owners of 3.4% of the Issuers outstanding shares of Common Stock. This percentage was calculated by dividing (i) 159,364 (representing 63,899 shares of Common Stock and 95,465 shares issuable upon the exercise of notes (the Note Shares)), by (ii) 4,627,504 the number shares of Common Stock (representing the number of issued and outstanding shares of Common Stock as of September 30, 2020, as reported in the Issuers Amendment No. 2 to Form S-1 filed with the Securities and Exchange Commission on December 28, 2020 together with the Note Shares).

(c)

The Fund has the sole power to vote and dispose of the 159,364 shares of Common Stock. The Delaware Street Capital Group has the shared power to vote and dispose of the 159,364 shares of Common Stock.

Item 5

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X].

Item 6

Ownership of More Than Five Percent on Behalf of Another Person.

Inapplicable.

Item 7

Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.

Inapplicable.

Item 8

Identification and Classification of Members of the Group.

Inapplicable.

Item 9

Notice of Dissolution of Group.

Inapplicable.

Item 10

Certification.

By signing below each of the Reporting Persons certifies that, to the best of such persons knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 16, 2021


Delaware Street Capital Master Fund, L.P.

By: DSC Managers, L.L.C., its general partner

By:		/s/ Andrew G. Bluhm
Name:		Andrew G. Bluhm
Title:		Managing Member


DSC Managers, L.L.C.

By:		/s/ Andrew G. Bluhm
Name:		Andrew G. Bluhm
Title:		Managing Member


DSC Advisors, L.P.

By: DSC Advisors, L.L.C., its general partner

By:		/s/ Andrew G. Bluhm
Name:		Andrew G. Bluhm
Title:		Managing Member


DSC Advisors, L.L.C.

By:		/s/ Andrew G. Bluhm
Name:		Andrew G. Bluhm
Title:		Managing Member

/s/ Andrew G. Bluhm

Andrew G. Bluhm